Amarin Corp Plc (AMRN)

[studythosestocks]

Discussions overheard by other general audience:
AMRN will not get approval for primary cohort but certainly will for secondary cohort. Label will discuss bleeding and afib trigs 150 and higher

Just people’s opinion. Take it for what it’s worth.

I personally don’t think a portion of the primary cohort is out of the picture yet but how do you pick and choose there. I think secondary cohort and primary cohort with 2 or more other CV risk factor beyond diabetes and on statin and trigs above 150 would calm a lot of the worries though and a label I could live with.